Risks and benefits of DNA testing for neurogenetic disorders

Seminars in Neurology

Volumn 19, Issue 3, 1999, Pages 253-260

  Bird, Thomas D ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

DNA testing; Genetic counseling; Neurogenetic disorders

Indexed keywords

ADOPTION; ALZHEIMER DISEASE; AMYLOID NEUROPATHY; ARTICLE; CANAVAN DISEASE; DNA DETERMINATION; DYSTONIA; FRAGILE X SYNDROME; FRIEDREICH ATAXIA; GAUCHER DISEASE; GENE MUTATION; GENETIC ASSOCIATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HEREDITARY OPTIC ATROPHY; HUNTINGTON CHOREA; INHERITANCE; KALLMANN SYNDROME; KEARNS SAYRE SYNDROME; KENNEDY DISEASE; LEGAL ASPECT; LESCH NYHAN SYNDROME; MEDICAL DECISION MAKING; MELAS SYNDROME; MULTIPLE ENDOCRINE NEOPLASIA; MUSCULAR DYSTROPHY; NEUROFIBROMATOSIS; NEUROLOGIC DISEASE; PELIZAEUS MERZBACHER DISEASE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TAY SACHS DISEASE; VON HIPPEL LINDAU DISEASE;

EID: 0032710350     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1040841     Document Type: Article

References (21)

1. Bird TD, Bennett RL. Why Do DNA Testing? Practical and ethical implications of new neurogenetic tests. Ann Neurol 1995;38: 141-146
2. Parboosingh JS, Figlewicz DA, Krizus A, et al. Spinobulbar muscular atrophy can mimic ALS: The importance of genetic testing in male patients with atypical ALS. Neurology 1997;49:568-572
3. Gharehbaghi-Schnell B, Finsterer J, Korschineck I, et al. Genotype-phenotype correlation in myotonic dystrophy. Clin Genet 1998;53:20-26
4. Moseley ML, Benzow KA, Schut LJ, Bird TD, et al. Incidence of dominant spinocerebellar and Friedreich triplet repeats among 361 ataxia families. Neurology 1998;51:1666-1671
5. Arikawa E, Hoffman EP, Kaido M, et al. The frequency of patients with dystrophin abnormalities in a limb-girdle patient population. Neurology 1991;41:1491-1496
6. Schöls L, Georgios A, Przuntek H, et al. Friedreich's ataxia: Revision of the phenotype according to molecular genetics. Brain 1997;120:2131-2140
7. De Jonghe P, Timmerman V, Nelis E, et al. Charcot-Marie-Tooth disease and related peripheral neuropathies. J Peripheral Nerv Syst 1997;2:370-387
8. Huggins M, Bloch M, Kanani S, et al. Ethical and legal dilemmas arising during predictive testing for adult-onset disease: The experience of Huntington disease. Am J Hum Genet 1990;47:4-12
9. Guidelines for the molecular genetics predictive test in Huntington's disease. Neurology 1994;44:1533-1536
10. Brinkman RR, Mezei MM, Theilmann J, et al. The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. Am J Hum Genet 1997;60:1202-1210
11. Lipe H, Schultz A, Bird TD. Risk factors for suicide in Huntington's disease: A retrospective case controlled study. Am J Med Genet 1993;48:231-233
12. Hayden MR, Bloch M, Wiggins S. Psychological effects of predictive testing for Huntington's disease. Behav Neurol Movement Disord 1995;65:201-210
13. Almqvist EW, Bloch M, Brinkman R, et al. A worldwide assessment of the frequency of suicide, suicide attempts or psychiatric hospitalization after predictive testing for Huntington disease. Am J Hum Genet 1999;64:1293-1304
14. Bird TD. Outrageous fortune: The risk of suicide in genetic testing for Huntington disease. Am J Hum Genet 1999;64:1289-1292
15. Bennett RL, Bird TD, Teri L. Offering predictive testing for Huntington disease in a medical genetics clinic: Practical applications. J Genet Counseling 1993;2:123-137
16. Billings PR, Kohn MA, de Cuevas M, et al. Discrimination as a consequence of genetic testing. Am J Hum Genet 1992;50:476-482
17. The ad hoc committee on genetic testing/insurance issue. Background statement. Am J Hum Genet 1995;56:327-331
18. Nance MA. Clinical aspects of CAG repeat diseases. Brain Pathol 1997;7:881-900
19. Wertz DC, Fanos JH, Reilly PR. Genetic testing for children and adolescents. Who decides? JAMA 1994;272:875-881
20. Levy-Lahad E, Bird TD. Genetic factors in Alzheimer's disease: A review of recent advances. Ann Neurol 1996;40:829-840
21. Jones KJ, Kim SS, North KN. Abnormalities of dystrophin, the sarcoglycans, and laminin α2 in the muscular dystrophies. J Med Genet 1998;35:379-386